Skip to main content
Top

Journal of Endocrinological Investigation

Issue 10/2008

Content (22 Articles)

Original Article

Role of calcium malabsorption in the development of secondary hyperparathyroidism after biliopancreatic diversion

J. A. Balsa, J. I. Botella-Carretero, R. Peromingo, I. Zamarrón, F. Arrieta, T. Muñoz-Malo, C. Vázquez

Iodine status and thyroid volume changes during pregnancy: Results of a survey in Aran Valley (Catalan Pyrenees)

L. Vila, G. Legaz, C. Barrionuevo, M. L. Espinel, R. Casamitjana, J. Muñoz, M. Serra-Prat, M. Puig-Domingo

Original Article

Prevalence and causes of undiagnosed hyperthyroidism in an adult healthy population. The Tromsø study

M. M. Bjørndal, K. Sandmo Wilhelmsen, T. Lu, R. Jorde

Original Article

Prevalence of interrelated autoantibodies in thyroid diseases and autoimmune disorders

H. Nakamura, T. Usa, M. Motomura, T. Ichikawa, K. Nakao, E. Kawasaki, M. Tanaka, K. Ishikawa, K. Eguchi

Original Article

Unexpected histological findings of lesions diagnosed in the adrenal region in a series of 420 patients submitted to adrenal surgery. Review of our experience

P. Iacconi, G. Donatini, C. Iacconi, C. De Bartolomeis, M. Cucinotta, M. Puccini, P. Miccoli

Original Article

Effects of estrogen and estrogen-progesteron on serum nitric oxide metabolite concentrations in post-menopausal women

G. Bednarek-Tupikowska, U. Tworowska-Bardzińska, K. Tupikowski

Original Article

Color-coded duplex endoscopic ultrasound of the adrenals

S. Meyer, M. A. v. Mach, D. Ivan, S. Schäfer, N. Habbe, B. Kann, P. H. Kann

Original Article

Absence of thyrotropin-induced increase in leptin levels in patients with history of differentiated thyroid carcinoma undergoing recombinant human thyrotropin testing

F. Cecoli, G. Andraghetti, C. Ghiara, L. Briatore, D. Cavallero, M. Mussap, F. Minuto, M. Giusti

Original Article

RAD52 polymorphisms contribute to the development of papillary thyroid cancer susceptibility in Middle Eastern population

A. K. Siraj, M. Al-Rasheed, M. Ibrahim, K. Siddiqui, F. Al-Dayel, O. Al-Sanea, S. Uddin, K. Al-Kuraya

Original Article

Hyperparathyroidism 2 gene (HRPT2, CDC73) and parafibromin studies in two patients with primary hyperparathyroidism and uncertain pathological assessment

F. Cetani, E. Pardi, E. Ambrogini, C. Banti, P. Viacava, S. Borsari, J. P. Bilezikian, A. Pinchera, C. Marcocci

Original Article

The genetic ascertainment of multiple endocrine neoplasia type 1 syndrome by ancient DNA analysis

F. Marini, S. Carbonell Sala, A. Falchetti, D. Caramelli, M. L. Brandi

Opinion

The management of the patient with acromegaly and headache: A still open clinical challenge

A. Giustina, M. Gola, A. Colao, L. De Marinis, M. Losa, N. Sicolo, E. Ghigo

Short Review

Cardiovascular aspects of primary hyperparathyroidism

M. D. Walker, S. J. Silverberg

Letter To The Editor

Improving the diagnosis of central hypothyroidism

V. Pezzino, C. Sipione, R. Vigneri

Letter To The Editor

Polycythemia as the first manifestation of Cushing’s disease

T. Dusek, D. Kastelan, M. Solak, S. Basic Kinda, I. Aganovic, M. Korsic

Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine